CORMEDIX INC. Earnings Per Share (Diluted)
CORMEDIX INC. (CRMD) reported Earnings Per Share (Diluted) of $0.29 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-13
- CORMEDIX INC. earnings per share, diluted for the quarter ending 2026-06-30 was $0.29, a 3.57% increase year-over-year.
- CORMEDIX INC. earnings per share, diluted for the quarter ending 2026-03-31 was $0.43, a 43.33% increase year-over-year.
- CORMEDIX INC. earnings per share, diluted for the quarter ending 2025-09-30 was $1.26.
- CORMEDIX INC. earnings per share, diluted for the quarter ending 2025-06-30 was $0.28.
- CORMEDIX INC. earnings per share, diluted for fiscal 2025 was $2.04.
- CORMEDIX INC. earnings per share, diluted for fiscal 2024 was -$0.30.
- CORMEDIX INC. earnings per share, diluted for fiscal 2023 was -$0.91.
- CORMEDIX INC. earnings per share, diluted for fiscal 2022 was -$0.74.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.29 10-Q · filed 2026-08-13 | $0.72 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $0.43 10-Q · filed 2026-05-14 | |||
| 2025-12-31 | $2.04 10-K · filed 2026-03-05 | |||
| 2025-09-30 | $1.26 10-Q · filed 2025-11-12 | $1.97 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $0.28 10-Q · filed 2026-08-13 | $0.58 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $0.30 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | -$0.30 10-K · filed 2026-03-05 | |||
| 2024-09-30 | -$0.05 10-Q · filed 2025-11-12 | -$0.54 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | -$0.25 10-Q · filed 2025-08-07 | -$0.50 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$0.25 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | -$0.91 10-K · filed 2025-03-25 | |||
| 2023-09-30 | -$0.17 10-Q · filed 2024-10-30 | -$0.65 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | -$0.25 10-Q · filed 2024-08-14 | -$0.49 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | -$0.24 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$0.74 10-K · filed 2024-03-12 | |||
| 2022-09-30 | -$0.17 10-Q · filed 2023-11-14 | -$0.54 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | -$0.19 10-Q · filed 2023-08-08 | -$0.38 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$0.18 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | -$0.75 10-K · filed 2023-03-30 | |||
| 2021-09-30 | -$0.22 10-Q · filed 2022-11-10 | -$0.54 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$0.12 10-Q · filed 2022-08-11 | -$0.32 10-Q · filed 2022-08-11 | ||
| 2015-06-30 | -$0.13 10-Q · filed 2015-08-06 | -$0.35 10-Q · filed 2015-08-06 | ||
| 2014-06-30 | -$0.05 10-Q · filed 2015-08-06 | -$0.64 10-Q · filed 2015-08-06 | ||
| 2013-06-30 | -$0.15 10-Q · filed 2014-08-14 | -$0.28 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |